Targeted FGFR Blockade for the Treatment of Tumor-Induced Osteomalacia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2020-10, Vol.383 (14), p.1387-1389
Hauptverfasser:	Hartley, Iris R, Miller, Carole B, Papadakis, Georgios Z, Bergwitz, Clemens, Del Rivero, Jaydira, Blau, Jenny E, Florenzano, Pablo, Berglund, Jason A, Tassone, Jing, Roszko, Kelly L, Moran, Susan, Gafni, Rachel I, Isaacs, Randi, Collins, Michael T
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Chondrosarcoma, Mesenchymal - complications Chondrosarcoma, Mesenchymal - secondary Disease Progression Fatal Outcome Fibroblast Growth Factors - antagonists & inhibitors Fibroblast Growth Factors - metabolism Humans Male Molecular Targeted Therapy Neoplasms, Connective Tissue - drug therapy Osteomalacia - drug therapy Osteomalacia - etiology Paraneoplastic Syndromes - drug therapy Phenylurea Compounds - adverse effects Phenylurea Compounds - therapeutic use Positron Emission Tomography Computed Tomography Pyrimidines - adverse effects Pyrimidines - therapeutic use Receptor Protein-Tyrosine Kinases - antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 1 - antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 1 - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!